EXHIBIT 11 CYTOCLONAL PHARMACEUTICS INC. COMPUTATION OF NET (LOSS) PER COMMON SHARE
Year Ended December 31, ----------------------------------------- 1998 1997 1996 ----------- ----------- ----------- Net (loss) $(2,728,000) $(3,252,000) $(2,890,000) Add cumulative preferred dividend (187,000) (234,000) (307,000) ----------- ----------- ----------- NET (LOSS) USED FOR COMPUTATION $(2,915,000) (3,486,000) $(3,197,000) Weighted average number of common shares outstanding - basic and diluted $ 9,742,000 $ 8,268,000 $ 7,640,000 ----------- ----------- ----------- Net (loss) per common share - basic and diluted $ (0.30) $ (0.42) $ (0.46)